0
Catabasis Pharmaceuticals, Inc. Banner Image

Catabasis Pharmaceuticals, Inc. has reached its limit for free report views

Work for Catabasis Pharmaceuticals, Inc.? Upgrade Your Profile and unlock all your annual reports.

Catabasis Pharmaceuticals, Inc.

  • Ticker CATB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Catabasis Pharmaceuticals, Inc. Logo Image
  • 11-50 Employees
  • Based in Boston, Massachusetts
At Catabasis Pharmaceuticals, their mission is to bring hope and life-changing therapies to patients and their families. Their lead program is edasalonexent, an NF-kB inhibitor in Phase 3 development for the treatment of Duchenne muscular dystrophy.
Catabasis Pharmaceuticals, Inc.

Most Recent Annual Report

Catabasis Pharmaceuticals, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Catabasis Pharmaceuticals, Inc. has reached its limit for free report views.

Older/Archived Annual Reports